SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-17-010229
Filing Date
2017-05-10
Accepted
2017-05-10 16:06:25
Documents
44
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q wve-10q_20170331.htm 10-Q 806427
2 EX-31.1 wve-ex311_14.htm EX-31.1 14928
3 EX-31.2 wve-ex312_8.htm EX-31.2 14919
4 EX-32 wve-ex32_10.htm EX-32 9114
  Complete submission text file 0001564590-17-010229.txt   2586942

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT wve-20170331.xml EX-101.INS 333596
6 XBRL TAXONOMY EXTENSION SCHEMA wve-20170331.xsd EX-101.SCH 26474
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE wve-20170331_cal.xml EX-101.CAL 32059
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE wve-20170331_def.xml EX-101.DEF 78707
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE wve-20170331_lab.xml EX-101.LAB 220048
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE wve-20170331_pre.xml EX-101.PRE 162604
Mailing Address 8 CROSS STREET #10-00 SINGAPORE U0 048424
Business Address 8 CROSS STREET #10-00 SINGAPORE U0 048424 617-206-4830
Wave Life Sciences Ltd. (Filer) CIK: 0001631574 (see all company filings)

IRS No.: 000000000 | State of Incorp.: U0 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37627 | Film No.: 17830235
SIC: 2834 Pharmaceutical Preparations